About: Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.92 (-7.11%)
ADIL NASDAQ Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc share price
Atividade de preço de ADIL
Último preço
$ 3,920
Variação (24h)
-0,30 USD (7,11%)
Volume
47.35K
Volume (média 4 sem.)
-
Abertura
$ 4,17
Variação do dia
$ 3,92 - $ 4,28
Fechamento anterior
$ 4,22
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
ADIL price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals